ECSP930986A - Nuevas composiciones basadas en derivados de nomegestrol y los procesos para su produccion - Google Patents

Nuevas composiciones basadas en derivados de nomegestrol y los procesos para su produccion

Info

Publication number
ECSP930986A
ECSP930986A EC1993000986A ECSP930986A ECSP930986A EC SP930986 A ECSP930986 A EC SP930986A EC 1993000986 A EC1993000986 A EC 1993000986A EC SP930986 A ECSP930986 A EC SP930986A EC SP930986 A ECSP930986 A EC SP930986A
Authority
EC
Ecuador
Prior art keywords
implants
new compositions
nomegestrol
derivatives
processes
Prior art date
Application number
EC1993000986A
Other languages
English (en)
Spanish (es)
Inventor
Michel Lanquetin
Jean-Louis Thomas
Jacques Paris
Elsimar Coutinho
Original Assignee
Theramex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theramex filed Critical Theramex
Publication of ECSP930986A publication Critical patent/ECSP930986A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Prostheses (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
EC1993000986A 1992-09-21 1993-10-04 Nuevas composiciones basadas en derivados de nomegestrol y los procesos para su produccion ECSP930986A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9211422A FR2695826B1 (fr) 1992-09-21 1992-09-21 Nouvelles compositions pharmaceutiques à base de dérivés de nomégestrol et leurs procédés d'obtention.

Publications (1)

Publication Number Publication Date
ECSP930986A true ECSP930986A (es) 1994-04-12

Family

ID=9433868

Family Applications (1)

Application Number Title Priority Date Filing Date
EC1993000986A ECSP930986A (es) 1992-09-21 1993-10-04 Nuevas composiciones basadas en derivados de nomegestrol y los procesos para su produccion

Country Status (31)

Country Link
US (1) US5565443A (ref)
EP (1) EP0613372B1 (ref)
JP (1) JPH08506318A (ref)
KR (1) KR100255700B1 (ref)
CN (1) CN1095667C (ref)
AP (1) AP497A (ref)
AT (1) ATE198275T1 (ref)
AU (1) AU683423B2 (ref)
BG (1) BG62317B1 (ref)
BR (1) BR9305642A (ref)
CA (1) CA2122827A1 (ref)
CZ (1) CZ284806B6 (ref)
DE (1) DE69329790D1 (ref)
DZ (1) DZ1717A1 (ref)
EC (1) ECSP930986A (ref)
FI (1) FI942272A7 (ref)
FR (1) FR2695826B1 (ref)
HU (1) HUT67044A (ref)
IL (1) IL107039A (ref)
MA (1) MA22978A1 (ref)
NO (1) NO306238B1 (ref)
OA (1) OA09924A (ref)
PL (1) PL176120B1 (ref)
RO (1) RO115783B1 (ref)
RU (1) RU2120797C1 (ref)
SK (1) SK54694A3 (ref)
TN (1) TNSN93104A1 (ref)
TW (1) TW381024B (ref)
WO (1) WO1994006437A1 (ref)
YU (1) YU60493A (ref)
ZA (1) ZA936964B (ref)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5660848A (en) * 1994-11-02 1997-08-26 The Population Council, Center For Biomedical Research Subdermally implantable device
FR2737411B1 (fr) * 1995-08-01 1997-10-17 Theramex Nouveaux medicaments hormonaux et leur utilisation pour la correction des carences estrogeniques
FR2754179B1 (fr) * 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
FR2776191B1 (fr) * 1998-03-23 2002-05-31 Theramex Composition hormonale topique a effet systemique
US6117441A (en) * 1998-07-02 2000-09-12 The Population Council, Inc. Silicone core long term androgen delivery implant
WO2001030356A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation
GB2355728A (en) * 1999-10-27 2001-05-02 Anson Medical Ltd Tubular medical implants and methods of manufacture
WO2002011768A1 (en) 2000-08-03 2002-02-14 Antares Pharma Ipl Ag Novel composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels
WO2005039531A1 (en) 2003-10-10 2005-05-06 Antares Pharma Ipl Ag Transdermal pharmaceutical formulation for minimizing skin residues
US7198801B2 (en) 2000-08-03 2007-04-03 Antares Pharma Ipl Ag Formulations for transdermal or transmucosal application
US8980290B2 (en) 2000-08-03 2015-03-17 Antares Pharma Ipl Ag Transdermal compositions for anticholinergic agents
JP4490095B2 (ja) 2001-06-29 2010-06-23 メドグラフト マイクロテック インコーポレイテッド 生体分解性の注入可能な移植物およびそれに関連する製造方法ならびに使用方法
PT2561860T (pt) * 2002-05-31 2018-05-08 Titan Pharmaceuticals Inc Dispositivo polimérico implantável para a libertação prolongada de buprenorfina
CA2520613C (en) 2003-03-31 2012-12-04 Titan Pharmaceuticals, Inc. Implantable polymeric device for sustained release of dopamine agonist
WO2004110400A2 (en) * 2003-05-30 2004-12-23 Titan Pharmaceuticals, Inc. Implantable polymeric device for sustained release of nalmefene
US7425340B2 (en) 2004-05-07 2008-09-16 Antares Pharma Ipl Ag Permeation enhancing compositions for anticholinergic agents
EP2594259A1 (en) 2004-08-04 2013-05-22 Brookwood Pharmaceuticals, Inc. Methods for manufacturing delivery devices and devices thereof
WO2006125642A1 (en) 2005-05-27 2006-11-30 Antares Pharma Ipl Ag Methods and apparatus for transdermal or transmucosal application of testosterone
NZ571460A (en) 2006-04-21 2010-10-29 Antares Pharma Ipl Ag Methods of treating hot flashes with formulations for transdermal or transmucosal application
FR2904213B1 (fr) * 2006-07-27 2008-10-10 Creaspine Soc Par Actions Simp Implant intervertebral destine a la fusion osseuse
CA2709712C (en) 2007-12-20 2016-05-10 Surmodics Pharmaceuticals, Inc. Process for preparing microparticles having a low residual solvent volume
EP2140860A1 (en) * 2008-07-03 2010-01-06 Bayer Schering Pharma Oy An improved method of contraception
GB2555373A (en) * 2016-08-23 2018-05-02 Reproductive Medicine And Gynaecology Associates Ltd Implant
US12582767B2 (en) 2021-12-30 2026-03-24 Taiyo Weber Compressible, minimally invasive implants and related systems and methods

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4147783A (en) * 1974-02-28 1979-04-03 Akzona Incorporated Oral pharmaceutical preparation
GB1515284A (en) * 1974-05-21 1978-06-21 Gastaud J Pharmaceutical compositions containing progestogens derived from the 17-alpha-hydroxy-19-nor-progesterone series
US4172132A (en) * 1977-07-26 1979-10-23 Schering Corporation 1,3,5(10),6,8,14-19-Nor-pregnahexaenes, their use as anti-psoriatic agents, and pharmaceutical formulations useful therefor
HU182775B (en) * 1981-10-15 1984-03-28 Richter Gedeon Vegyeszet Process for preparing new 3-chloro-pregnane derivatives
US5223492A (en) * 1987-10-27 1993-06-29 Nasraoui Nejib M Derivatives of 19-nor progesterone; process for producing them and the pharmaceutical compositions incorporating them
FR2664895B1 (fr) * 1990-07-20 1992-10-30 Theramex Laboratoire Nouveaux derives de la 6-methyl 19-nor progesterone, substitues en 3 et leur procede d'obtention.

Also Published As

Publication number Publication date
PL176120B1 (pl) 1999-04-30
TNSN93104A1 (fr) 1994-03-17
CN1095667C (zh) 2002-12-11
CA2122827A1 (fr) 1994-03-31
EP0613372A1 (fr) 1994-09-07
BG62317B1 (bg) 1999-08-31
FI942272L (fi) 1994-05-16
HUT67044A (en) 1995-01-30
IL107039A0 (en) 1993-12-28
FI942272A0 (fi) 1994-05-16
KR100255700B1 (ko) 2000-08-01
SK54694A3 (en) 1994-10-05
AP497A (en) 1996-05-28
OA09924A (fr) 1994-09-15
CZ116494A3 (en) 1995-03-15
CZ284806B6 (cs) 1999-03-17
CN1094284A (zh) 1994-11-02
AU4822993A (en) 1994-04-12
EP0613372B1 (fr) 2000-12-27
MA22978A1 (fr) 1994-04-01
BR9305642A (pt) 1996-01-09
NO306238B1 (no) 1999-10-11
ZA936964B (en) 1994-04-14
BG98776A (bg) 1995-02-28
JPH08506318A (ja) 1996-07-09
NO941900L (no) 1994-05-24
YU60493A (sh) 1997-01-08
IL107039A (en) 1999-01-26
FI942272A7 (fi) 1994-05-16
AP9300576A0 (ref) 1993-10-31
ATE198275T1 (de) 2001-01-15
AU683423B2 (en) 1997-11-13
DZ1717A1 (fr) 2002-02-17
TW381024B (en) 2000-02-01
FR2695826B1 (fr) 1995-01-06
WO1994006437A1 (fr) 1994-03-31
US5565443A (en) 1996-10-15
RO115783B1 (ro) 2000-06-30
DE69329790D1 (de) 2001-02-01
HU9401395D0 (en) 1994-08-29
NO941900D0 (no) 1994-05-20
RU2120797C1 (ru) 1998-10-27
FR2695826A1 (fr) 1994-03-25

Similar Documents

Publication Publication Date Title
EP1562565B1 (de) Verwendung eines oder mehrerer der elemente aus der gruppe yttrium, neodym und zirconium
ES2167377T3 (es) Derivados de piridina farmacologicamente activos y procedimientos para la preparacion de los mismos.
DE69224131T2 (de) Polymerzusammensetzungen zur Verwendung als Implantate mit verzögerter Abgabe
ES2068999T3 (es) Composiciones para la liberacion retardada de clorhexidina.
DE10311729A1 (de) Endovaskuläres Implantat mit einer mindestens abschnittsweisen aktiven Beschichtung aus Ratjadon und/oder einem Ratjadon-Derivat
ECSP941104A (es) Derivados de 2,6 diaminopurina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
ES2145118T3 (es) Derivados de acidos grasos y composiciones farmaceuticas que los contienen.
ES2184895T3 (es) Sistema no polimerico de administracion con liberacion retardada.
ES2098262T3 (es) Derivados de bacterioclorofila-a utiles en terapia fotodinamica.
BR0112361A (pt) Métodos para tratamento de condições oculares mediadas por inflamação
ES2058592T3 (es) El uso de sustancias activas fisiologicamente para la fabricacion de medicamentos para enfermedades cerebrales y neuronales.
ES2178668T3 (es) Naftilamidas como agentes del sistema nervioso central.
ES2044912T3 (es) Composiciones farmaceuticas dotadas de actividad secuestrante para los acidos biliares, conteniendo colestiramina como principio activo, y procedimiento para su preparacion.
RU94026906A (ru) Новые композиции в форме подкожных инплантантов на основе производных нормегестрола, способ их получения и применения
AR003427A1 (es) Péptidos relacionados con dolastatina, procedimiento para prepararlos, composiciones farmacéuticas que los contienen y el uso de los mismos para la preparación de dichas composiciones farmacéuticas.
ATE336997T1 (de) Fulvinsäure und dessen verwendung zur behandlung von diversen krankheitszuständen
DE60032594T2 (de) Verwendung von pirenoxin zum schutz des kornealgewebes während photokeratektomie
DE2022117C3 (de) Pulverförmige Ausgangsmischung für die unter Methacrylsäuremethylester-Zusatz erfolgende Herstellung von Knochenzement
BR0010983A (pt) Preparações para a aplicação de agentes antiinflamatórios
ES2158223T3 (es) Utilizacion de derivados de hidantoina para la preparacion de un medicamento para el tratamiento de las enfermedades asociadas con la presencia de oxigeno activo y de radicales libres.
ATE121293T1 (de) Verwendung eines stoffes, dessen hauptbestandteil ein triglyzerid ist, als wirkstoff mit biologischer wirkung auf die darmmucosa sowie zubereitung die diesen wirkstoff enthält.
DE59005456D1 (de) Cytostatische und cytotoxische Wirkstoffkombination zur Anwendung in therapeutischen Verfahren.
ES2084057T3 (es) Bacterina para el tratamiento de enfermedades causadas por f. necrophorum y procedimiento para su produccion.
ES2110057T3 (es) Composicion medicinal que contiene tcf-ii.
ATE160573T1 (de) 1,3.5 (10) - estratriene derivate mit oraler wirkung